Related Experiment Video
Updated: Jun 10, 2026

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
Published on: April 17, 2017
Associations between serum lipids and hepatitis C antiviral treatment efficacy
Darmendra Ramcharran1, Abdus S Wahed, Hari S Conjeevaram
1Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA. dramcharran@gmail.com
Insights
Serum lipids impact hepatitis C virus (HCV) treatment success, but do not explain why African Americans respond less to antiviral therapy. Lower triglycerides and higher LDL cholesterol at baseline predicted better outcomes.
Area of Science:
- Hepatology
- Virology
- Biochemistry
Background:
- Chronic hepatitis C virus (HCV) genotype 1 infection has suboptimal treatment response rates.
- A significant disparity exists in treatment efficacy between African Americans (AAs) and Caucasian Americans (CAs).
- Serum lipid profiles are increasingly recognized as potential factors influencing HCV treatment outcomes.
Purpose of the Study:
- To investigate the association between baseline and dynamic changes in serum lipids and virological response to antiviral therapy in HCV genotype 1 patients.
- To determine if serum lipid profiles explain the observed racial differences in treatment efficacy between AAs and CAs.
- To explore the impact of peginterferon alfa-2a plus ribavirin therapy on serum lipid levels in relation to race.
Main Methods:
- Prospective cohort study (Virahep-C) of treatment-naïve patients with HCV genotype 1.
- Analysis of fasting serum lipids at baseline, during, and after antiviral therapy (peginterferon alfa-2a plus ribavirin).
- Statistical modeling (relative risk) to identify factors associated with sustained virological response (SVR), including lipid parameters and race.
Main Results:
- Antiviral therapy induced significant changes in serum lipids, with variations observed based on race and treatment dosage.
- Lower baseline triglyceride levels and higher baseline low-density lipoprotein cholesterol levels were independently associated with increased SVR rates.
- An interaction between high-density lipoprotein cholesterol and gender influenced SVR, but overall lipid measures did not account for the racial disparity in treatment response.
Conclusions:
- Serum lipid profiles are correlated with sustained virological response in chronic hepatitis C patients.
- While lipids influence treatment outcomes, they do not explain the lower response rates observed in African Americans compared to Caucasian Americans.
- These findings may inform future therapeutic strategies targeting lipid metabolism for HCV eradication.
Unlabelled:
Approximately one half of patients who undergo antiviral therapy for chronic hepatitis C virus (HCV) genotype 1 infection do not respond to treatment. African Americans (AAs) are less responsive to treatment than Caucasian Americans (CAs), but the reasons for this disparity are largely unknown. Recent studies suggest that serum lipids may be associated with treatment response. The aims of this study were to evaluate baseline and changes in serum lipids during therapy, determine whether serum lipids are associated with virological response, and assess whether these measures explain the racial difference in efficacy. The study participants were from Virahep-C, a prospective study of treatment-naïve patients with genotype 1 HCV infection who received peginterferon (PEG-IN) alfa-2a plus ribavirin therapy for up to 48 weeks. Fasting serum lipids were analyzed at baseline and during and after therapy in 160 AAs and 170 CAs. A relative risk (RR) model was employed to evaluate characteristics associated with sustained virological response (SVR). Antiviral therapy was associated with changes in serum lipids during and after antiviral therapy, with the changes differing by race and the amount of PEG-IFN taken. Baseline lipid measures independently associated with higher rates of SVR were lower triglyceride and higher low-density lipoprotein cholesterol, with an interaction between high-density lipoprotein cholesterol (HDLc) and gender. Lipid measures did not contribute significantly to an explanation of the racial difference in SVR.
Conclusion:
Serum lipids are associated with SVR, although these paramaters did not explain the racial difference in treatment response. The results of this study are compatible with proposed biological mechanisms of HCV entry, replication, and secretion, and may underscore new potential therapeutic targets for HCV eradication.
More Related Videos
Related Concept Videos
Hepatitis
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Viral Hepatitis I: Introduction
Inhibitors of Viral Protein Synthesis
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

